T Sivashanmugam1, Indubala Maurya, Naveen Kumar, Manoj K Karmakar. 1. From the Department of Anesthesiology and Critical Care, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth, Pillayarkuppam, Pondicherry, India (TS, IM, NK) and Department of Anaesthesia & Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China (MKK).
Abstract
BACKGROUND: The costoclavicular brachial plexus block (BPB) produces faster onset of sensory motor blockade than the lateral sagittal approach. However, the incidence of phrenic nerve palsy (PNP) after a costoclavicular BPB is not known. OBJECTIVES: The current study compared the incidence of ipsilateral hemidiaphragmatic paresis, and thus PNP, between a supraclavicular and costoclavicular BPB. DESIGN: Randomised observer blinded study. SETTING: Operating room. PATIENTS: Forty patients undergoing right-sided upper extremity surgery. INTERVENTION: All patients received either a supraclavicular group or costoclavicular group BPB using 20 ml of an equal mixture of 0.5% bupivacaine and 2% lidocaine with 1 : 200 000 epinephrine. MAIN OUTCOME MEASURES: Measurements included ipsilateral hemidiaphragmatic excursion and peak expiratory flow rate (PEFR) taken before and at 30 min after the BPB. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre. Ipsilateral PNP was defined as a reduction in hemidiaphragmatic excursion by at least 50% during deep breathing at 30 min after the BPB. RESULTS: The incidence of ipsilateral PNP was lower (P = 0.008) in the costoclavicular group (5%) than in the supraclavicular group (45%). Fewer (P = 0.04) patients in the costoclavicular group [1(5%)] exhibited a positive sniff test, with paradoxical movement of the diaphragm, than in the supraclavicular group [7(35%)]. PEFRs were similar (P = 0.09) between the groups. When ipsilateral hemidiaphragmatic paresis was present, the median reduction in PEFR was 32% (interquartile range 23.6 to 45.5%). CONCLUSION: Costoclavicular BPB produces a lower incidence of ipsilateral PNP than a supraclavicular BPB. NAME OF REGISTRY: Clinical Trial Registry of India. IDENTIFIER: CTRI/2017/09/009763.
RCT Entities:
BACKGROUND: The costoclavicular brachial plexus block (BPB) produces faster onset of sensory motor blockade than the lateral sagittal approach. However, the incidence of phrenic nerve palsy (PNP) after a costoclavicular BPB is not known. OBJECTIVES: The current study compared the incidence of ipsilateral hemidiaphragmatic paresis, and thus PNP, between a supraclavicular and costoclavicular BPB. DESIGN: Randomised observer blinded study. SETTING: Operating room. PATIENTS: Forty patients undergoing right-sided upper extremity surgery. INTERVENTION: All patients received either a supraclavicular group or costoclavicular group BPB using 20 ml of an equal mixture of 0.5% bupivacaine and 2% lidocaine with 1 : 200 000 epinephrine. MAIN OUTCOME MEASURES: Measurements included ipsilateral hemidiaphragmatic excursion and peak expiratory flow rate (PEFR) taken before and at 30 min after the BPB. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre. Ipsilateral PNP was defined as a reduction in hemidiaphragmatic excursion by at least 50% during deep breathing at 30 min after the BPB. RESULTS: The incidence of ipsilateral PNP was lower (P = 0.008) in the costoclavicular group (5%) than in the supraclavicular group (45%). Fewer (P = 0.04) patients in the costoclavicular group [1(5%)] exhibited a positive sniff test, with paradoxical movement of the diaphragm, than in the supraclavicular group [7(35%)]. PEFRs were similar (P = 0.09) between the groups. When ipsilateral hemidiaphragmatic paresis was present, the median reduction in PEFR was 32% (interquartile range 23.6 to 45.5%). CONCLUSION:Costoclavicular BPB produces a lower incidence of ipsilateral PNP than a supraclavicular BPB. NAME OF REGISTRY: Clinical Trial Registry of India. IDENTIFIER: CTRI/2017/09/009763.
Authors: Tiffany R Tedore; Hannah X Lin; Kane O Pryor; Virginia E Tangel; Daniel J Pak; Michael Akerman; David S Wellman; Hannah Oden-Brunson Journal: Reg Anesth Pain Med Date: 2020-10-01 Impact factor: 6.288